Clinical trial
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
NCT02741323 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 1, 2017
- Completion date
- May 10, 2022
- Enrollment
- 97 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.